Joshua J. Ofman
CEO & DirectorDr. Joshua J. Ofman, also known as Josh, MD, M.S.H.S, serves as Director since March 12, 2026 and serves as its Chief Executive Officer since June 01, 2026 and served as its Chief Medical Officer and Head of External Affairs. Dr. Ofman was President of GRAIL, Inc. Dr. Ofman joined GRAIL in 2019 and has extensive experience in clinical medicine, biopharmaceutical leadership, health policy and precision medicine. He served as Chief Medical Officer and External Affairs at GRAIL, Inc. since 2020 until January 2021. Dr. Ofman served as Chief of Corporate Strategy until 2020. Dr. Ofman has been Director of California Life Sciences Association since August 20, 2019. He was Senior Vice President of Global Health Policy at Amgen Inc. since March 2019 until 2019. Dr. Ofman had been Senior Vice President of Global Value, Access and Policy at Amgen Inc. since December 7, 2016 until March, 2019. Dr. Ofman served as Senior Vice President of Global Value and Access at Amgen Inc. until December 7, 2016 and also served as its Vice President of Reimbursement and Payment Policy since July 2004. Dr. Ofman was responsible for the design and execution of Amgen's reimbursement and payment strategy and helps to ensure the integration of reimbursement needs into the product development and commercialization process. He joined Amgen in 2003 as senior director, U.S. Medical Affairs and head of Amgen's U.S. Health Economics and Outcomes Research group. Prior to Amgen, Dr. Ofman was an academic gastroenterologist at Cedars-Sinai Health System and Senior Vice President of Zynx Health Inc., a subsidiary of Cerner Corp., a publicly traded healthcare information technology company. He served as Vice Chairman at National Pharmaceutical Council since November 2015 and serves as its a Director. He served as a Member of the Medical Advisory Board of Santarus, Inc. Dr. Ofman serves as Assistant Professor of University of California at Los Angeles, School of Medicine; Assistant Professor of Cedars-Sinai Departments of Medicine and Health Services Research; Assistant Professor of Cedars-Sinai, Division of Gastroenterology. He conducted his internship and residency in internal medicine and fellowship in digestive diseases at the University of California, Los Angeles (UCLA) Department of Medicine. Dr. Ofman completed a RAND/VA/UCLA fellowship in ambulatory care and health services research, specializing in technology assessment and received a Masters of Science in Health Services from the UCLA School of Public Health. Dr. Ofman obtained his undergraduate degree from the University of California at Berkeley and his M.D. from the University of California, Irvine College of Medicine.
Positions
- Company NameGRAIL, Inc.Stock CodeGRALPositionCEO & DirectorColleagues
- GLGregory L. SummeIndependent Chairman of the Board
- AFAaron FreidinCFO & Head of Corporate Development
- RPRobert P. RagusaAdvisor
- PCPaul CiccolellaSenior Vice President of Global Development & Operations
- SASatnam AlagChief Technology Officer
- WJWilliam J. ChaseIndependent Director
- SCSteven C. MizellIndependent Director
- SKSarah KrevansIndependent Director
